AG Myelodysplastische Syndrome
Welcome to the website of the Dresden MDS Working Group!
Our aim is to provide current and novel therapeutic strategies for patients with Myelodysplastic Syndromes (MDS) and to explore the pathobiology of this disease in a translational way.
Our main research interests include:
- Dissecting inflammatory pathways in MDS with a particular emphasis on S100A8/9
- Revealing specific metabolic signatures in various cellular and humoral compartments of MDS patients
- Investigating the role of the microbiome in MDS pathobiology
- Novel diagnostic tools
We are honored to possess close collaborations with the Dresden Stem Cell Lab, the Institute for Clinical Chemistry and Laboratory Medicine, the working group “AI in cancer”, the working group “Oncomechanics”, the German MDS Study Group and EMBL Heidelberg.
We are always open to new ideas and collaborations - feel free to contact us.
Our department is certified as an “MDS Center of Excellence” by The Myelodysplastic Syndrome Foundation, Inc..
contact
- Dr. med. K. Sockel Katja Sockel
- Dr. med. E. Balaian Ekaterina Balaian